Publications

Late Breaking Abstract - Patients with Severe Eosinophilic Asthma Achieved Remission over 2 Years with Benralizumab: Integrated Analysis of the ≫1000-Patient, Multinational, Real-World Xaloc-1 Study

AuthID
P-00Z-QRE

Author(s)

Pelaia, G

Jackson, DJ

Nair, P

Emmanuel, B

Tran, TN

Menzies Gow, A

Watt, M

Kayaniyil, S

Boarino, S

Nuevo, J

Pardal, M

Shavit, A

Shih, V

Cohen, D

Loureiro, C

Padilla Galo, A

Document Type

Abstract

Year published

2023

Published

in EUROPEAN RESPIRATORY JOURNAL, ISSN: 0903-1936

Volume: 62

Conference

Annual Congress of the European-Respiratory-Society (Ers), Date: SEP 09-13, 2023, Location: Milan, IA

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1183/13993003.congress-2023.pa4131

Wos: WOS:001109120507256

Source Identifiers

ISSN: 0903-1936

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Late Breaking Abstract - Patients with Severe Eosinophilic Asthma Achieved Remission over 2 Years with Benralizumab: Integrated Analysis of the ≫1000-Patient, Multinational, Real-World Xaloc-1 Study

Useful Links

Get Help

Federated Authentication (Click on the image)

Late Breaking Abstract - Patients with Severe Eosinophilic Asthma Achieved Remission over 2 Years with Benralizumab: Integrated Analysis of the ≫1000-Patient, Multinational, Real-World Xaloc-1 Study

Useful Links

Get Help